NADMED was chosen among the best clinical laboratory services in Europe. The selection was made by one of the Europe’s leading health tech magazines Life Science Review. The magazine interviewed NADMED’s COO Jana Buzkova, who tells about the new standards...
The easy and reliable method that measures all NAD metabolites has also convinced financiers. NADMED recently completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the...
NADMED raised a lot of interest among the VC investors at Nordic Life Science days 2022 in Malmö, Sweden. Investors were particularly enthusiastic about NADMED’s first three quarters’ business development. NADMED is currently growing rapidly selling...
Leaders in the aging and longevity field are gathered in the 9th Aging Research and Drug Discovery meeting in Copenhagen from 29th of August. NADMED is joining the event where the experts will describe the latest progress in the molecular, cellular and organismal...
NADMED’s new website was published in the end of June 2022. Designers’ goal was to build a visually rewarding yet simple site which will provide the necessary information about NADMED’s technology, products and services for researchers, medical...
